奥拉帕尼
同源重组
PARP抑制剂
聚ADP核糖聚合酶
雷达51
PARP1
DNA修复
DNA损伤
生物
细胞生物学
复制蛋白A
DNA
分子生物学
癌症研究
聚合酶
遗传学
DNA结合蛋白
基因
转录因子
作者
Samuele Lodovichi,Roberto Quadri,Sarah Sertic,Achille Pellicioli
出处
期刊:Cell Reports
[Elsevier]
日期:2023-02-01
卷期号:42 (2): 112060-112060
被引量:5
标识
DOI:10.1016/j.celrep.2023.112060
摘要
The nucleolytic processing (resection) of a DNA double-strand break (DSB) is a critical step to repair the lesion by homologous recombination (HR). PARylation, which is the attachment of poly(ADP-ribose) (PAR) units to specific targets by PAR polymerases (PARPs), regulates many steps of HR, including resection. Here, we show that preventing PARylation of the oncosuppressor BRCA1 induces hyper-resection of DSBs through BRCA2 and the EXO1 nuclease. Upon expression of the unPARylatable variant of BRCA1, we observe a reduced 53BP1-RIF1 barrier for resection accompanied by an increase in the recruitment of the RAD51 recombinase. Similar results are observed when cells are treated with the clinically approved PARP inhibitor olaparib. We propose that PARylation of BRCA1 is important to limit the formation of excessively extended DNA filaments, thereby reducing illegitimate chromosome rearrangements. Our results shed light on molecular aspects of HR and on the mechanisms of PARP inhibitor treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI